Day: October 8, 2025

RUTHERFORD, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, October 29, 2025 it will release financial results for the quarter ended September 30, 2025. A copy of the earnings release will be available on the Company’s website, https://ir.bluefoundrybank.com/, in the “News” section and on the SEC’s website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, October 29, 2025 at 11:00AM (ET) to discuss Third Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts. The conference call will be recorded and will be available on the Company’s website for one month. We encourage participants to pre-register...

Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity Partners, a multi-family asset management firm based in Chicago, for consideration of up to $60 million in cash, consisting of an upfront payment of $45 million, and up to $15 million payable in the future upon the achievement of certain milestones. “This transaction represents a positive outcome for Enovis, our Dr. Comfort business, and Promus Equity Partners,” said Damien McDonald, Enovis’ Chief Executive Officer. “The sale sharpens our focus on Enovis’ core strengths and market leadership in Prevention & Recovery. By streamlining our portfolio we are creating a stronger...

VANCOUVER, British Columbia, Oct. 08, 2025 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) is pleased to announce the closing of the previously announced bought deal offering of 5,991,500 common shares of the Company (the “Common Shares”), at a price of C$24.00 per Common Share (the “Offering Price”) for gross proceeds of C$143,796,000 (the “Offering”), which includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 781,500 Common Shares at the Offering Price. The Common Shares are offered by way of a prospectus supplement to the Company’s base shelf prospectus (the “Base Shelf Prospectus”) in all of the provinces of Canada, excluding Quebec. The Common Shares are also offered by way of a U.S. prospectus...

New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirements AI-Immunology™, already superior in vaccine target discovery, now also enables enhanced design applicable for both new vaccines and optimization of approved ones Evaxion will present detailed validation data on these improvements at the World Vaccine Congress Europe in Amsterdam on October 15, 2025COPENHAGEN, Denmark, October 8, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, is launching a significant improvement of its already leading AI-platform, AI-Immunology™, with a new automated vaccine design module. Uniquely, the new module automatically provides vaccine designs...

ECD’s Boutique Division Completes a Beautifully Appointed, Custom 993; Project GravettePhoto Credit: Dan Watson Studios (Image Library Link) KISSIMMEE, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (NASDAQ: ECDA) (“ECD” or the “Company”), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs, today announced its entry into the Porsche 911 restoration and customization market through its Boutique Division. The debut vehicle, Project Gravette, is a fully bespoke Porsche 993 restored through the immersive, one-of-one luxury design experience that defines every ECD build. Driven by strong demand from ECD’s loyal customer base, the Company is expanding into the Porsche segment, offering...

ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the third quarter 2025 after the U.S. market close on Wednesday, November 5th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call DetailsInvestors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/. About MaxCyteAt...

Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with One of the Industry’s Fastest Growth Rates CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, today announced the launch of Daily Ultimate Longevity from its rapidly scaling IM8 Health brand co-founded by David Beckham. Daily Ultimate Longevity is the first supplement scientifically formulated to comprehensively target all 12 hallmarks of aging, reinforcing IM8’s position as one of the fastest-growing supplement brand in industry history. Since its full December 2024 launch, IM8 has achieved an extraordinary compound annual growth rate of 2,457%, with monthly revenue scaling from ~$600,000 to $6.6 million by...

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the third quarter ended Sept. 30, 2025, on Tuesday, Oct 28, 2025, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company’s investor relations website offering an overview of the financial results. The company will host a conference call at 10:00 a.m. EDT the following day, Wednesday, Oct. 29, 2025, with Chairman and Chief Executive Officer Rohit Kapoor and Executive Vice President and Chief Financial Officer Maurizio Nicolelli, who will provide insights into the company’s operational and financial results. To listen to video live webcast or to participate in the call, please register here. A replay of the webcast will...

ATHENS, Greece, Oct. 08, 2025 (GLOBE NEWSWIRE) — C3is Inc. (NASDAQ: CISS) (the “Company”), a ship-owning company providing dry bulk and tanker seaborne transportation services, today announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of 800,000 shares of its Common Stock at a public offering price of $2.50, for an aggregate offering price of $2.0 million. Aggregate gross proceeds to the Company are expected to be approximately $2.0 million. The transaction is expected to close on or about October 9, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. is acting...